We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.17B
AUM Growth
+$164M
Cap. Flow
+$157M
Cap. Flow %
13.37%
Top 10 Hldgs %
25.72%
Holding
3,876
New
301
Increased
2,412
Reduced
769
Closed
99

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.19M
2
NVDA icon
NVIDIA
NVDA
+$5.82M
3
MSFT icon
Microsoft
MSFT
+$5.63M
4
AMZN icon
Amazon
AMZN
+$4.37M
5
TSLA icon
Tesla
TSLA
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 24.89%
2 Financials 12.52%
3 Consumer Discretionary 8.81%
4 Healthcare 7.95%
5 Industrials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOLF icon
1901
Acushnet Holdings
GOLF
$5.34B
$23.6K ﹤0.01%
332
+17
+5% +$1.16K
BBCA icon
1902
JPMorgan BetaBuilders Canada ETF
BBCA
$11.3B
$23.3K ﹤0.01%
330
UFPT icon
1903
UFP Technologies
UFPT
$2.51B
$23.2K ﹤0.01%
95
-42
-31% -$12.2K
AOSL icon
1904
Alpha and Omega Semiconductor
AOSL
$1.03B
$23.2K ﹤0.01%
627
+364
+138% +$13.6K
CHWY icon
1905
Chewy
CHWY
$9.25B
$23.2K ﹤0.01%
+693
New +$21.6K
BROS icon
1906
Dutch Bros
BROS
$8.96B
$23.2K ﹤0.01%
443
+220
+99% +$9.71K
FSP
1907
Franklin Street Properties
FSP
$45.3M
$23.2K ﹤0.01%
12,658
NABL icon
1908
N-able
NABL
$605M
$23.1K ﹤0.01%
2,478
-1,734
-41% -$19.4K
NOV icon
1909
NOV
NOV
$7.38B
$23.1K ﹤0.01%
1,583
-3,606
-69% -$56.3K
PTCT icon
1910
PTC Therapeutics
PTCT
$6.23B
$23.1K ﹤0.01%
511
+274
+116% +$11.7K
GXO icon
1911
GXO Logistics
GXO
$5.4B
$23.1K ﹤0.01%
530
+1
+0.2% +$55
CUZ icon
1912
Cousins Properties
CUZ
$4.83B
$23K ﹤0.01%
751
+225
+43% +$6.9K
RYZ
1913
Ryerson Holding Corp
RYZ
$1.45B
$23K ﹤0.01%
1,241
+1,070
+626% +$24K
FXR icon
1914
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$762M
$23K ﹤0.01%
307
-357
-54% -$27.9K
FEP icon
1915
First Trust Europe AlphaDEX Fund
FEP
$531M
$23K ﹤0.01%
+641
New +$23.8K
CM icon
1916
Canadian Imperial Bank of Commerce
CM
$109B
$23K ﹤0.01%
363
HUBG icon
1917
HUB Group
HUBG
$2.9B
$22.8K ﹤0.01%
512
-199
-28% -$9.29K
TCBK icon
1918
TriCo Bancshares
TCBK
$1.82B
$22.8K ﹤0.01%
521
+39
+8% +$1.77K
HTO
1919
H2O America
HTO
$2.56B
$22.7K ﹤0.01%
462
+115
+33% +$6.33K
ITUB icon
1920
Itaú Unibanco
ITUB
$86.9B
$22.6K ﹤0.01%
5,170
-948
-15% -$4.88K
RWL icon
1921
Invesco S&P 500 Revenue ETF
RWL
$9.95B
$22.6K ﹤0.01%
231
PEB icon
1922
Pebblebrook Hotel Trust
PEB
$2B
$22.5K ﹤0.01%
1,661
+377
+29% +$4.98K
BLX icon
1923
Bladex Inc
BLX
$2.1B
$22.5K ﹤0.01%
632
+33
+6% +$1.12K
ASIX icon
1924
AdvanSix
ASIX
$438M
$22.4K ﹤0.01%
788
+753
+2,151% +$22.8K
NTCT icon
1925
NETSCOUT
NTCT
$2.81B
$22.4K ﹤0.01%
1,035
+244
+31% +$5.29K

Similar funds

GAMMA Investing's Q4 2024 Portfolio in Review

As of Q4 2024, GAMMA Investing held 3,876 positions worth $1.17B, up 16% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $157M of net new capital in Q4 2024, opening 301 new positions and adding to 2,412 existing holdings. Its largest new stake was iShares China Large-Cap ETF: 7,320 shares worth $223K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.01M trimmed.

  • GAMMA Investing's largest Q4 2024 buy was iShares China Large-Cap ETF: 7,320 shares worth $223K.
  • GAMMA Investing added most to Apple in Q4 2024, an estimated $7.19M increase.
  • GAMMA Investing's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.01M.
  • GAMMA Investing fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $634K.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.17B portfolio in Q4 2024.
  • GAMMA Investing opened 301 new positions and closed 99 in Q4 2024.
  • GAMMA Investing's portfolio value rose 16% quarter-over-quarter to $1.17B.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.